CSS
LUXAU

Cubist Systematic Strategies’s Lux Health Tech Acquisition Corp. Units LUXAU Stock Holding History

Cubist Systematic Strategies’s Portfolio LUXAU Stock Details LUXAU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-106,373
Closed -$1.05M – 5005
2022
Q2 		$1.05M Buy
+106,373
New +$1.06M 0.01% 2438

Other funds holding LUXAU

BP
BBR Partners New York $1.79B AUM 16.83% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Cubist Systematic Strategies's LUXAU Position: Q3 2022 in Review

Cubist Systematic Strategies sold out of Lux Health Tech Acquisition Corp. Units (LUXAU) in Q3 2022, closing a stake of 106,373 shares — an estimated $1.05M sold.

Cubist Systematic Strategies first reported a position in LUXAU in Q2 2022 and held it in 1 quarter. The position peaked at $1.05M in Q2 2022. 9 funds tracked by Wall St. Rank hold LUXAU as of Q3 2022.

  • Cubist Systematic Strategies reported no remaining Lux Health Tech Acquisition Corp. Units position as of Q3 2022 after selling out during the quarter.
  • Cubist Systematic Strategies sold 106,373 Lux Health Tech Acquisition Corp. Units shares in Q3 2022, an estimated $1.05M.
  • Cubist Systematic Strategies first reported a position in Lux Health Tech Acquisition Corp. Units in Q2 2022 and held it in 1 quarter.
  • Cubist Systematic Strategies's Lux Health Tech Acquisition Corp. Units position peaked at $1.05M in Q2 2022.
  • 9 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Units as of Q3 2022.

Based on Cubist Systematic Strategies's 13F filing for Q3 2022, filed 14 Nov 2022.